Cart
sales@molnova.com
(D-Trp32)-Neuropeptide Y (human, rat)
CAS No. 178861-83-1
(D-Trp32)-Neuropeptide Y (human, rat)( ——— )
Catalog No. M40277 CAS No. 178861-83-1
(D-Trp32)-Neuropeptide Y (human, rat)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(D-Trp32)-Neuropeptide Y (human, rat)
-
NoteResearch use only, not for human use.
-
Brief Description(D-Trp32)-Neuropeptide Y (human, rat)
-
Description(D-Trp32)-Neuropeptide Y (human, rat)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number178861-83-1
-
Formula Weight4356.9
-
Molecular FormulaC196H288N56O56S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
KKI-5
KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.
-
9-Ethylguanine
9-Ethylguanine is a model nucleobase commonly used in the studies of DNA interactions with organometallic complexes.
-
Letolizumab
Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.
